Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06292260Not ApplicableRecruiting

Digital Toolkit for Skin Diseases in LMICs: Part 2

Role: collaborator

NCT05300399Not ApplicableUnknown

Digital Toolkit for Skin Diseases in LMICs

Role: collaborator

NCT03922594Terminated

Surveillance of Zika-related Microcephaly in Sub-Saharan Africa and Asia

Role: collaborator

NCT03388034Completed

Pertussis Immunization Programs in Low Income Countries - Ivory Coast

Role: collaborator

All 4 trials loaded